AstraZeneca PLC/ GB0009895292 /
| 6/6/2023 3:34:15 PM | Chg. +86.00 | Volume | Bid3:34:15 PM | Ask3:34:15 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 11,870.00GBX | +0.73% | 113,176 Turnover(GBP): 13.4 mill. |
11,866.00Bid Size: 35 | 11,872.00Ask Size: 123 | 183.98 bill.GBP | - | - |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 2.12 USD | 2,550.00% |
| EPS Diluted: | - USD | 2,537.50% |
| Revenues per Share: | 28.61 USD | 8.44% |
| Book Value per Share: | 23.89 USD | -13.76% |
| Cash Flow per Share: | 6.33 USD | 50.47% |
| Dividend per Share: | 2.90 USD | 3.57% |
| Total | in mill. | |
| Revenues: | 44,351.00 USD | 18.53% |
| Net Income: | 3,228.00 USD | 2,782.14% |
| Operating Cash Flow: | 9,808.00 USD | - |
| Cash and Cash Equivalents: | 6,166.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 69.68 | - |
| P/S Ratio: | 5.16 | - |
| P/BV ratio: | 6.18 | - |
| P/CF Ratio: | 23.35 | - |
| PEG: | 0.03 | - |
| Earnings Yield: | 1.44% | - |
| Dividend Yield: | 1.96% | - |
| Market Capitalization | ||
| Market Capitalization: | 183.98 bill. GBP | 0.0000 GBP |
| Free Float Market Cap.: | 135.41 bill. GBP | - GBP |
| Market Cap. / Employee: | 2.2 mill. GBP | - GBP |
| Shares Outstanding: | 1.55 bill. | |
Profitability
| Gross Profit Margin: | 72.06% |
| EBIT Margin: | 8.47% |
| Net Profit Margin: | 7.28% |
| Return on Equity: | 8.72% |
| Return on Assets: | 3.35% |
Financial Strength
| Liquidity I / Cash Ratio: | 23.45% |
| Liquidity II / Quick Ratio: | 51.10% |
| Liquidity III / Current Ratio: | 85.93% |
| Debt / Equity Ratio: | 160.50% |
| Dynam. Debt / Equity Ratio: | 606.10% |
Efficiency
| Employees: | 83,500 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | 531,149.70 USD |
| Net Income / Employee: | 38,658.68 USD |
| Total Assets / Employee: | 1,155,485.03 USD |
| * Fiscal Year End: | 12/31/2022 |
| Accounting Standard: | IFRS |
| Currency: | USD |